Keller Eric L.
SEC insider (Form 3/4/5 filer). CIK 0002156365. CHIEF EXECUTIVE OFFICER at Retension Pharmaceuticals, Inc. (RTSN). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in FALLS CHURCH, VA.
Companies Keller Eric L. has filed insider reports for
- Retension Pharmaceuticals, Inc. (RTSN): Director, Officer, CHIEF EXECUTIVE OFFICER
Keller Eric L.
CIK: 0002156365
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Retension Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 22, 2026RTSN
Retension Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
40.9K shares- - Oct 13, 2026RTSN
Retension Pharmaceuticals, Inc.
PurchaseDirect20.8K shares at avg. $12.00$250K - Oct 13, 2026RTSN
Retension Pharmaceuticals, Inc.
ConversionDirect9.7K shares- - Oct 13, 2026RTSN
Retension Pharmaceuticals, Inc.
ConversionDirect31.4K shares- - Oct 13, 2026RTSN
Retension Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
255.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 | RTSN Retension Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 40,884 | - | - | Direct |
| Oct 13, 2026 | RTSN Retension Pharmaceuticals, Inc. | Purchase | 20,800 | $12.00 | $249,600 | Direct |
| Oct 13, 2026 | RTSN Retension Pharmaceuticals, Inc. | Conversion | 9,662 | - | $0 | Direct |
| Oct 13, 2026 | RTSN Retension Pharmaceuticals, Inc. | Conversion | 31,368 | - | $0 | Direct |
| Oct 13, 2026 | RTSN Retension Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 255,174 | - | - | Direct |
1-5 of 5 transactions